Trials / Completed
CompletedNCT02117739
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Almirall, S.A. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the potential of dapsone gel and its vehicle to cause a photoallergic reaction after repeated application and irradiation to the skin of healthy volunteers under controlled conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dapsone gel | Patches containing dapsone gel will be applied to the skin. |
| DRUG | dapsone gel vehicle | Patches containing dapsone gel vehicle will be applied to the skin. |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-04-21
- Last updated
- 2018-10-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02117739. Inclusion in this directory is not an endorsement.